LIBERVANT, a diazepam buccal formulation based on PharmFilm technology serves as a beacon of hope, offering convenient alternatives to existing device-based products, for managing acute repetitive seizure emergencies in young patients.
LIBERVANT utilizes "fast-melt strips" for "buccal delivery of diazepam, offering promises to rewrite the narrative of acute repetitive seizure emergencies, ushering in an era of renewed optimism and therapeutic advancement.
At the 76th Annual Meeting of the American Academy of Neurology (AAN) 2024 in Denver from April 13 to 18, Aquestive Therapeutics presented an abstract for the crossover study data evaluating th...
